Free Trial

Fiduciary Trust Co Buys 4,853 Shares of The Procter & Gamble Company (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Fiduciary Trust Co boosted its holdings in The Procter & Gamble Company (NYSE:PG - Free Report) by 1.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 372,684 shares of the company's stock after buying an additional 4,853 shares during the period. Procter & Gamble makes up about 0.8% of Fiduciary Trust Co's investment portfolio, making the stock its 22nd biggest position. Fiduciary Trust Co's holdings in Procter & Gamble were worth $62,480,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Cladis Investment Advisory LLC raised its holdings in shares of Procter & Gamble by 5.2% during the fourth quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock worth $806,000 after acquiring an additional 236 shares during the period. FAS Wealth Partners Inc. raised its holdings in shares of Procter & Gamble by 2.0% during the fourth quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock worth $4,642,000 after acquiring an additional 549 shares during the period. Berkshire Asset Management LLC PA raised its holdings in shares of Procter & Gamble by 0.9% during the fourth quarter. Berkshire Asset Management LLC PA now owns 236,616 shares of the company's stock worth $38,833,000 after acquiring an additional 2,179 shares during the period. Strategic Advisors LLC raised its holdings in shares of Procter & Gamble by 3.4% during the fourth quarter. Strategic Advisors LLC now owns 55,912 shares of the company's stock worth $9,374,000 after acquiring an additional 1,818 shares during the period. Finally, Richard C. Young & CO. LTD. raised its holdings in shares of Procter & Gamble by 2.1% during the fourth quarter. Richard C. Young & CO. LTD. now owns 123,853 shares of the company's stock worth $20,764,000 after acquiring an additional 2,568 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

PG stock traded down $0.92 during trading on Friday, reaching $157.73. 6,450,866 shares of the company were exchanged, compared to its average volume of 7,201,672. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The Procter & Gamble Company has a twelve month low of $156.58 and a twelve month high of $180.43. The company has a 50-day moving average of $165.92 and a two-hundred day moving average of $167.54. The company has a market capitalization of $369.80 billion, a price-to-earnings ratio of 25.12, a P/E/G ratio of 3.76 and a beta of 0.41.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.01. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm had revenue of $19.78 billion during the quarter, compared to analysts' expectations of $20.42 billion. During the same period in the prior year, the company posted $1.52 EPS. The company's revenue was down 2.1% on a year-over-year basis. As a group, equities analysts predict that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Monday, April 21st will be given a $1.0568 dividend. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 annualized dividend and a yield of 2.68%. The ex-dividend date of this dividend is Monday, April 21st. Procter & Gamble's dividend payout ratio is 66.98%.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Gary A. Coombe sold 18,000 shares of the company's stock in a transaction on Tuesday, February 25th. The shares were sold at an average price of $171.66, for a total value of $3,089,880.00. Following the sale, the chief executive officer now directly owns 22,051 shares of the company's stock, valued at approximately $3,785,274.66. This represents a 44.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the completion of the sale, the chief executive officer now directly owns 51,965 shares in the company, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 64,520 shares of company stock worth $10,999,268. 0.18% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

PG has been the topic of several recent research reports. Redburn Atlantic lowered shares of Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price target on the stock. in a research note on Thursday, May 1st. Piper Sandler lifted their price objective on shares of Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a research report on Monday, May 5th. JPMorgan Chase & Co. reduced their target price on shares of Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating for the company in a report on Friday, April 11th. Raymond James cut their price objective on shares of Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating for the company in a report on Friday, April 25th. Finally, DA Davidson reissued a "buy" rating and issued a $209.00 price objective on shares of Procter & Gamble in a report on Thursday, January 23rd. Eight equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $178.52.

Check Out Our Latest Stock Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines